near significancep = 0.058
Patients with high level of HSP60 tended to have a better OS than those with low level of HSP60, a more dramatic difference was observed after a 60 month-time point, demonstrating near significance ( p = 0.058).
Patients with high level of HSP60 tended to have a better OS than those with low level of HSP60, a more dramatic difference was observed after a 60 month-time point, demonstrating near significance ( p = 0.058).
Despite a stable overall incidence rate and steadily improving survival rates in recent years, there is an increasing trend of early-onset CRC cases and challenging 5-year survival rates in more aggressive stages [ 2 ].
The highlight of the findings was that three different antibodies, pan-specific for Her2 (NK054-2, NK054-4 and NK054-5), showed a trend of enhanced signal intensity between normal samples and tumour samples.